STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.
STAT [Unofficial]
March 19, 2026
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval.
Discussion in the ATmosphere